LYTIR

Company · FLNA

Filana Therapeutics, Inc.

Name as listed on its exchange; filed with the SEC as FILANA THERAPEUTICS, INC.

Nasdaq's symbol directory lists FLNA on Nasdaq as “Filana Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 6 occasions ($628K); 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $628K in total; Insider sales: $0 in total.Sep: Insider purchases $356KNov: Insider purchases $271KDecJanFebMarAprMayJunJulAugSepOctNov$356K
Insider purchases above the line: $628KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Barry Richard, President & CEO bought on 4 days latest Nov 16, 2026 bought $563K
  2. Cook Robert Christopher, Chief Operating& Legal Officer bought on 1 day latest Nov 16, 2026 bought $56K
  3. Schoen Eric, Chief Financial Officer bought on 1 day latest Nov 16, 2026 bought $8K
Every trade (6)
  1. BUYBarry Richard, President & CEO bought Nov 16, 2026 440,206 shares filing $207K
  2. BUYCook Robert Christopher, Chief Operating& Legal Officer bought Nov 16, 2026 121,575 shares filing $56K
  3. BUYSchoen Eric, Chief Financial Officer bought Nov 16, 2026 20,000 shares filing $8K
  4. BUYBarry Richard, President & CEO bought Sep 30, 2026 100,000 shares filing $92K
  5. BUYBarry Richard, President & CEO bought Sep 29, 2026 206,813 shares filing $186K
  6. BUYBarry Richard, President & CEO bought Sep 28, 2026 93,091 shares filing $78K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Departure or appointment of directors or officers; Regulation FD disclosure filing Nov 12, 2026
  2. Results of operations and financial condition filing Nov 5, 2026
  3. Other events filing Oct 20, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.